μ Opioid receptor gene variants: Lack of association with alcohol dependence

Molecular Psychiatry

Volumn 2, Issue 6, 1997, Pages 490-494

  Bergen, A W ^a   Kokoszka, J ^a   Peterson, R ^a   Long, J C ^a   Virkkunen, M ^b   Linnoila, M ^a   Goldman, D ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alcoholism; OPRM1; Polymorphism; Substance abuse; Opioid receptor

Indexed keywords

BETA ENDORPHIN; MU OPIATE RECEPTOR; OPIATE; ENDORPHIN; RECEPTOR PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG DEPENDENCE; FEMALE; GENE; GENE LOCUS; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RECEPTOR GENE; AMERICAN INDIAN; AMINO ACID SUBSTITUTION; CAUCASIAN; CLINICAL ARTICLE; FINLAND; NORMAL HUMAN; PHENOTYPE; PROTEIN POLYMORPHISM; PROTEIN VARIANT; UNITED STATES;

EID: 0031414904     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000331     Document Type: Article

References (42)

1. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology 1997; 129: 99-111.
2. Kreek MJ. Opiates, opioids and addiction. Mol Psychiatry 1996; 1: 232-254.
3. Gianoulakis C, Barcomb A. Effect of acute ethanol in vivo and in vitro on the B-endorphin system in the rat. Life Sci 1987; 40: 19-28.
4. Reid LD, Hunter GA. Morphine and naloxone modulate intake of ethanol. Alcohol 1984; 1: 33-37.
5. Altschuler HL, Phillips PE, Feinhandler DA. Alteration of ethanol self-administration by naltrexone. Life Sci 1980; 26: 679-688.
6. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-5278.
7. Berrettini W, Ferraro T, Alexander R, Buchberg A, Vogel W. Quantitative trait loci study of morphine preference in inbred mouse strains. Nature Genet 1994; 17: 54-58.
8. Alexander RC, Heydt D, Ferraro TN, Vogel W, Berrettini WH. Further evidence for a quantitative trait locus on murine chromosome 10 controlling morphine preference in inbred mice. Psych Genet 1996; 6: 29-31.
9. Volpicelli JR. Uncontrollable events and alcohol drinking. Br J Addict 1987; 82: 381-392.
10. Gianoulakis C, Beliveau D, Angelogianni P, Meaney M, Thavundayil J, Tawar V et al. Different pituitary B-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci 1989; 45: 1097-1109.
11. Peterson JB, Pihl RO, Gianoulakis C, Conrod P, Finn PR, Stewart SH, LeMarquand DG et al. Ethanol-induced change in cardiac and endogenous opiate function and risk for alcoholism. Alcoholism: Clin Exper Res 1996; 20: 1542-1552.
12. King AC, Volpicelli JR, Frazer A, O'Brien CP. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 1997; 129: 15-22.
13. Wang JB, Johnson PS, Persico A, Hawkins AL, Griffin CA, Uhl GR. Human mu opiate receptor: cDNA and genomic clones, pharmacological characterization and chromosomal assignment. FEBS Lett 1994; 338: 217-222.
14. Bare LA, Mansson E, Yang D. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett 1994; 354: 213-216.
15. Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian M et al. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci 1995; 15: 2396-2406.
16. Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE, Uhl GR. mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci USA 1993; 90: 10230-10234.
17. Surratt CK, Johnson PS, Moriwaki A, Seidleck BK, Blaschak CJ, Wang JB et al. μ opiate receptor: charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J Biol Chem 1994; 269: 20548-20553.
18. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414-9419.
19. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB. Influence of beta-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 25-33.
20. Liles WC, Nathanson NM. Regulation of neuronal muscarinic receptor number by protein glycosylation. J Neurochem 1986; 46: 85-95.
21. Unterwald EM, Rubenfeld JM, Imai Y, Wang JB, Uhl GR, Kreek MJ. Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels. Mol Brain Res 1995; 33: 351-355.
22. Kieffer BL. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobio 1995; 15: 615-635.
23. Melo JA, Shendure J, Pociask K, Silver LM. Identification of sex-specific quantitative trait loci controlling alcohol preference in C57BL/6 mice. Nature Genet 1996; 13: 147-153.
24. Market PD, Bennett B, Beeson M, Cordon L, Johnson TE. Confirmation of quantitative trait loci for ethanol sensitivity in long-sleep and short-sleep mice. Genome Res 1997; 7: 92-99.
25. Kozak CA, Filie J, Adamson MC, Chen Y, Yu L. 1994. Murine chromosomal location of the μ and κ opioid receptor genes. Genomics 1994; 21: 659-661.
26. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, New Jersey, 1988.
28. Thomasson HR, Edenberg HJ, Cragg DW, Mai X-L, Jerome RE, Li T-K et al. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese mon. Am J Hum Genet 1991; 48: 677-681.
29. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid receptor gene. Nature 1996; 383: 819-823.
30. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM et al. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 1997; 94: 1544-1549.
31. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. J Am Med Assoc 1965; 193: 80-84.
32. Martin WR, Jasinski DR, Mansky PA. Naltrexone, an antagonist for the treatment of heroin dependence. Arch Gen Psych 1973; 28: 784-791.
33. O'Malley SS, Jaffe A, Chang G, Schottenfeld RS, Meyer RE, Rounsaville BJ. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psych 1992; 49: 881-887.
34. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrezone in the treatment of alcohol dependence. Arch Gen Psych 1992; 49: 876-880.
35. Zadina JE, Hackler L, Ce L-J, Kastin AJ. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 1997; 386: 499-502.
36. Enoch M-A, Rohrbaugh JW, Davis EZ, Harris CR, Ellingson RJ, Andreason P et al. Relationship of genetically transmitted alpha EEG traits to anxiety disorders and alcoholism. Am J Med Gen (Neuropsych Gen) 1995; 60: 400-408.
37. Virkkunen M, Rawlings R, Tokola R, Pland RE, Guidotti A, Nereroff C et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psych 1994; 51: 20-27.
38. Virkkunen M, Kallio E, Rawlings R, Tokola R, Pland RE, Guidotti A et al. Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psych 1994; 51: 28-33.
39. Goldman D, Urbanek M, Guenther D, Robin R, Long JC. Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians. Am J Med Gen (Neuropsych Gen) 1997; 74: 386-394.
40. A structural variants with allele-specific amplification and electrochemiluminescent detection. Hum Mut 1996; 7: 135-143.
41. Simonin F, Gaveriaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G et al. κ-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc Natl Acad Sci USA 1995; 92: 7006-7010.
42. Statistical Analysis for Genetic Epidemiology, Release 22. Computer program package available from the Department of Biometry and Genetics, LSU Medical Center, New Orleans, supported by a USPHS Resource Grant (1 P41 RR03655) from the Division of Research Resources.